Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis-Reference-Cited by-同舟云学术

Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis

Published:2021-07-24 Issue:1 Volume:29 Page:96-104
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Gangoda Lahiru,Schenk Robyn L.,Best Sarah A.^ORCID,Nedeva Christina,Louis Cynthia^ORCID,D’Silva Damian B.,Fairfax Kirsten,Jarnicki Andrew G.,Puthalakath Hamsa^ORCID,Sutherland Kate D.^ORCID,Strasser Andreas^ORCID,Herold Marco J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

https://www.nature.com/articles/s41418-021-00839-3.pdf

Reference48 articles.

1. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805–20.

2. Yip KW, Reed JC. Bcl-2 family proteins and cancer. Oncogene. 2008;27:6398–406.

3. Vogler M. BCL2A1: the underdog in the BCL2 family. Cell Death Differ. 2012;19:67–74.

4. Lin EY, Orlofsky A, Berger MS, Prystowsky MB. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to Bcl-2. J Immunol. 1993;151:1979–88.

5. Karsan A, Yee E, Kaushansky K, Harlan JM. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood. 1996;87:3089–96.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacteria-derived extracellular vesicles: endogenous roles, therapeutic potentials and their biomimetics for the treatment and prevention of sepsis;Frontiers in Immunology;2024-02-13

2. Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context;Egyptian Journal of Medical Human Genetics;2024-01-27

3. Macrophage polarization and metabolism in atherosclerosis;Cell Death & Disease;2023-10-20

4. A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation;EMBO reports;2023-10-17

5. Genome editing of PAR2 through targeted delivery of CRISPR-Cas9 system for alleviating acute lung inflammation via ERK/NLRP3/IL-1β and NO/iNOS signalling;Acta Pharmaceutica Sinica B;2023-08